{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-108078","form_type":"8-K","ticker":"CARM","cik":"0001485003","company_name":"Carisma Therapeutics Inc.","filed_at":"2024-10-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.562676+00:00","generated_at":"2026-05-30T15:20:12.288368+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Carisma Therapeutics receives Nasdaq deficiency notice for market value below $50M","bullets":["Nasdaq notified Carisma on Oct 10, 2024 that MVLS fell below $50M minimum requirement.","Company has 180 days, until April 8, 2025, to regain compliance by closing at $50M+ for 10 consecutive days.","Failure to regain compliance may lead to delisting; company can appeal to a Nasdaq Hearing Panel.","Carisma will monitor MVLS and evaluate options to meet Nasdaq listing standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-108078","json":"https://secwatch.observer/filing/0001104659-24-108078.json","markdown":"https://secwatch.observer/filing/0001104659-24-108078.md","text":"https://secwatch.observer/filing/0001104659-24-108078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924108078/0001104659-24-108078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924108078/tm2426043d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T15:20:12.288368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}